About

In 2019, I joined the Santagata Lab at Brigham and Women's Hospital as a research assistant and have been conducting groundbreaking cancer research ever since. Now I am dually affiliated with both BWH and the Laboratory Systems of Pharmacology at Harvard Medical School allowing me to maintain close collaborations with researchers from some of the top institutions: Harvard Medical School, Dana Farber Cancer Institute, and MIT's Koch Institute.

My primary research focus has been on using tissue-based cyclic immunofluorescence (t-CyCIF) and genetically engineered mouse models (GEMMs) to better characterize the spatial features of the tumor microenvironment (TME). With CyCIF, I acquire highly multiplexed single cell protein data while preserving spatial context. This allows me to conduct deep immune phenotyping of the TME and explore cell-cell interactions with neighborhood analysis techniques. Pairing CyCIF with tractable mouse models enables us to understand how genetic perturbations and novel therapies alter the immune response in a controlled manner. Therefore, we can start to interrogate how different cancers evade immune surveillance (i.e. t-cell exhaustion, t-cell exclusion, M2 macrophage recruitment, etc.) and identify features of the tumor microenvironment that are indicative of therapeutic response. 

I received my Bachelor of Science in Biomedical Engineering from Georgia Tech and plan on attending medical school. One day, I aspire to be a physician-scientist that plays a translational role within the field of immunotherapy and optimizes combination therapies in the clinic using precision medicine. I am primarily interested in neoantigen vaccination and identifying promising biomarkers for checkpoint therapy. 

Research Interests: Oncology, Immunotherapy, Single Cell Data, Machine Learning